SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
24.00
-0.72 (-2.91%)
Oct 16, 2026, 4:00 PM EDT - Market closed
SpyGlass Pharma Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, SpyGlass Pharma stock has a consensus rating of "Strong Buy" and an average price target of $44. The average 1-year stock price forecast is 83.33% higher than the current stock price, while the lowest is $37 (+54.17%) and the highest is $62 (+158.33%).
Price Target: $44 (+83.33%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SpyGlass Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | May '26 | Jun '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $37 | Buy | Reiterates | $37 | +54.17% | Oct 5, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $42 | Buy | Maintains | $42 | +75.00% | Oct 2, 2026 |
| Raymond James | Raymond James | Buy Initiates $39 | Buy | Initiates | $39 | +62.50% | Aug 14, 2026 |
| Jefferies | Jefferies | Buy Maintains $62 | Buy | Maintains | $62 | +158.33% | May 19, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.50
from -1.96
EPS Next Year
-2.81
from -2.50
EPS and Forward PE are based on non-GAAP adjusted numbers.